- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
It is pretty clear that the medical community has become much more political and far less medical since the beginning of this century. This is why HHS Secretary Kennedy wants to break the iron grip the political left has on health care journals. Health care research has suffered:
https://www.city-journal.org/article/jama-network-science-diseases-dei-inequity
Leading Medical Journals Care More About DEI Than Major Diseases
A new report finds that the JAMA Network ran more articles recently mentioning “inequity” than “asthma.”
By Howard H. Fenn and Kurt Miceli - July 22 2025In his novel The Magic Mountain, Thomas Mann describes wealthy European consumptives who retreat to a sanitorium high in the Swiss Alps, convinced that thin air aids in treating pulmonary tuberculosis. In their self-contained community, they affirm their faith in contemporary medical practices while delaying the demands of life in the “flatlands.”
Medical researchers, it seems, are retreating to a sanatorium of their own. Based on our analysis, leading medical journals increasingly lean left and are abandoning scientific principles in service of progressive ideology.
We began by conducting a keyword search of every article published in the JAMA Network—a group of 13 medical journals affiliated with the American Medical Association—between April 1 and May 31. The phrase “diversity, equity, and inclusion” appeared 56 times, more often than atherosclerosis (45) and osteoporosis (16). Another progressive-coded term, “inequity,” showed up 99 times—more than asthma (75) or opioid use disorder (65).
Phrase Searched Number of Results
chronic kidney disease 128
inequity 99
asthma 75
opioid use disorder 65
structural discrimination 61
diversity, equity, and inclusion 56
congestive heart failure 53
atherosclerosis 45
structural racism 36
historically marginalized group 33
osteoporosis 16
intersectionality 13Number of search results from the JAMA Network (April 1, 2025–May 31, 2025)
To assess the political valence of the articles, we performed a qualitative review of the 56 DEI papers. We asked two free online artificial intelligence chatbots—xAI’s Grok 3 and Microsoft’s Copilot—to rate the political bias of each of those articles on a scale from -5 (strongly left-leaning) to 5 (strongly right-leaning). We instructed the AI systems to assess each article according to various criteria, including language, framing, tone, and policy implications. We then averaged the chatbots’ scores.
The results revealed a decided left-wing slant. The average score across all 56 articles was -2.02. Seven scored -3.5 and six scored -3. Not one article leaned right.
What explains these findings? One potential explanation is that the network’s editors believe their readership is predominantly left-wing. That assumption was made plain in a recent editor’s note, published in response to the National Institute of Health’s cap on indirect costs. “Many JAMA readers hope that the NIH and HHS will lose these legal cases,” the note read, “and that the new 15% indirect cost rate will be struck down.” Fiscally conservative readers may have had a different view.
These findings reflect a broader leftward shift in medical research—one that has contributed to the scientific establishment’s erosion of rigor and objectivity. This shift threatens the foundations of the profession, the integrity of research, and the quality of medical education.
DEI-inspired scientific studies are often plagued by poor design: sampling bias, lack of proper control groups, leading survey questions, and circular reasoning. Researchers frequently treat incidental associations as proof of causation. These methodological flaws are baked into published papers, which then get cited, flaws and all, by others. Over time, some DEI-based studies acquire unwarranted credibility and authority.
Take Brad Greenwood and colleagues’ research from 2020, which claimed that “newborn-physician racial concordance”—meaning the child and the doctor are the same race—“is associated with a significant improvement in mortality for Black infants.” But the original authors failed to control for babies with very low birth weight. When Manhattan Institute researchers replicated the study, they found that racial concordance had no such effect. Nonetheless, the original study has received more than 800 citations, including 21 by articles within the JAMA Network.
Another study with similar left-wing premises has also made the rounds. Kelly Hoffman and colleagues claimed in a 2016 paper that “Black Americans are systematically undertreated for pain relative to white Americans.” Their conclusion was based on a sample of 194 medical students and 28 residents, with no attending physicians included except for “10 experienced physicians,” whose recommendations served as the benchmark against which sample participants’ knowledge was evaluated.
In one of the paper’s two case vignettes, these physicians identified narcotics as the appropriate pain management for kidney stones. Had they consulted the 7th edition of Tintinalli’s Emergency Medicine Manual from 2012, however, those physicians would have known that NSAIDs are the “primary analgesic of choice” for that condition, not opiates. While this error calls into question the study’s conclusions, the paper nevertheless has been cited over 3,000 times, according to Google Scholar.
Residents of the academy’s Magic Mountain are sustained by skewed evidence and increasingly disconnected from reality. They would do well to step away from the illusion of certainty and return to the foundations of scientific inquiry—rigorous debate, objective analysis, and a plurality of perspectives.
Howard H. Fenn is a clinical psychiatrist certified by the American Board of Psychiatry and Neurology with additional qualifications in geriatric psychiatry. Kurt Miceli serves as medical director for Do No Harm, a membership organization representing health-care professionals, patients, and policymakers focused on keeping identity politics out of medicine.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














